Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Positief advies voor lecanemab (Leqembi) bij beperkte groep alzheimerpatiënten
nov 2024 | Dementie